Patent US5469843A successfully refreshed from Google Patents.
US5469843A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Inhalation device
Assignee: 3M Co
•
Filing: 1992-11-06
•
Granted: 1995-11-28
•
Expires: 2012-11-06
Abstract
Abstract The present invention relates to a dry powder inhaler having one or more deaglommeration channels through which an airstream containing entrained medicament particles passes. Each channel has a substantially constant cross-sectional area and a bend having a radius of curvature of no greater than 10 mm.
Inventors
- 👤 Peter D. Hodson
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-24 21:53
CPC Classifications
A; A61; A61M; A61M15/00; A61M15/0091; A61M11/00; A61M11/001; A61M11/002; A61M15/0001; A61M15/0021; A61M15/0028; A61M15/0045; A61M15/0046; A61M15/0051; A61M15/0093; A61M15/0096; A61M2202/00; A61M2202/06; A61M2202/064
Claims Analysis
Total Claims: 13
Claim 1
Independent Claim
214 words
A dry powder inhaler for dispensing powdered medicament, comprising a housing defining a chamber for receiving a dose of powdered medicament, one or more air inlets, and a patient port adapted for insertion into the mouth or nasal passage of the patient, said housing being constructed and arranged to provide an air passage extending from the air inlet(s) through the chamber to the patient port so that patient inhalation at the patient port generates an airstream through the inhaler which entrains particles of medicament from the chamber for inhalation by the patient, the air passage being provided with one or more deagglomeration channels between the chamber and patient port through which the airstream with entrained medicament must pass, each channel having a substantially constant cross-sectional profile with a cross-sectional area no greater than 40 mm 2 , a first opening communicating with the chamber, a second opening communicating with the patient port, and adjacent said first opening a first bend of 35° to 200° and adjacent said second opening a second bend of 35° to 200°, wherein the minimum radius of curvature of the center of each of the first and second bends is no greater than 10 mm, said first and second bends being of opposite-handedness so as to form an S shape.
Claim 2
Dependent Claim
214 words
A dry powder inhaler for dispensing powdered medicament, comprising a housing defining a chamber for receiving a dose of powdered medicament, one or more air inlets, and a patient port adapted for insertion into the mouth or nasal passage of the patient, said housing being constructed and arranged to provide an air passage extending from the air inlet(s) through the chamber to the patient port so that patient inhalation at the patient port generates an airstream through the inhaler which entrains particles of medicament from the chamber for inhalation by the patient, the air passage being provided with one or more deagglomeration channels between the chamber and patient port through which the airstream with entrained medicament must pass, each channel having a substantially constant cross-sectional profile with a cross-sectional area no greater than 40 mm 2 , a first opening communicating with the chamber, a second opening communicating with the patient port, and adjacent said first opening a first bend of 35° to 200° and adjacent said second opening a second bend of 35° to 200°, wherein the minimum radius of curvature of the center of each of the first and second bends is no greater than 10 mm, said first and second bends being of opposite-handedness so as to form an S shape.
Claim 3
Dependent Claim
28 words
A dry powder inhaler as claimed in claim 1 in which the one or more deagglomeration channel(s) has a cross-sectional area no greater than 30 mm 2 .
Claim 4
Dependent Claim
29 words
A dry powder inhaler as claimed in claim 1 in which the one or more deagglomeration channel(s) has a cross-sectional area of from 15 to 25 mm 2 .
Claim 5
Dependent Claim
33 words
A dry powder inhaler as claimed in claim 1 in which the minimum radius of curvature of the center of each of the first and second bends is no greater than 5 mm.
Claim 6
Dependent Claim
33 words
A dry powder inhaler as claimed in claim 4 in which the minimum radius of curvature of the center of each of the first and second bends is from 1.5 to 5 mm.
Claim 7
Dependent Claim
23 words
A dry powder inhaler as claimed in claim 1 wherein the first bend is about 150° and the second bend is about 135°.
Claim 8
Dependent Claim
34 words
A dry powder inhaler as claimed in claim 1 in which the overall path length between the first and second openings of the one or more deagglomeration channel(s) is no greater than 4 cm.
Claim 9
Dependent Claim
33 words
A dry powder inhaler as claimed in claim 1 in which the one or more deagglomeration channel(s) has a rectangular cross-section of length 8 to 30 mm and width 1 to 2.5 mm.
Claim 10
Dependent Claim
33 words
A dry powder inhaler as claimed in claim 1 in which the one or more deagglomeration channel(s) has a rectangular cross-section of length 8 to 16 mm and width 1.2 to 1.6 mm.
Claim 11
Dependent Claim
25 words
A dry powder inhaler as claimed in claim 8 wherein the one or more deagglomeration channel(s) has an enlarged portion formed along the center thereof.
Claim 12
Dependent Claim
27 words
A dry powder inhaler as claimed in claim 1 in which the one or more deagglomeration channel(s) has a circular cross-section of diameter 2 to 7 mm.
Claim 13
Dependent Claim
23 words
A dry powder inhaler as claimed in claim 1 in which the one or more deagglomeration channel(s) is formed in the patient port.
References Cited (Backward Citations)
US2674999A
Cited
US2587215A
Cited
GB1118341A
Cited
US3669113A
Cited
GB1268051A
Cited
GB1478138A
Cited
US3971377A
Cited
US4240418A
Cited
US4046146A
Cited
GB1526303A
Cited
US4098273A
Cited
US3948264A
Cited
US4137914A
Cited
US4147166A
Cited
US4192309A
Cited
GB2041763A
Cited
GB2061735A
Cited
US4667668A
Cited
US4674491A
Cited
GB2165159A
Cited
US4907583A
Cited
EP0237507B1
Cited
GB2191718A
Cited
US4846168A
Cited
WO1990007351A1
Cited
WO1990013327A1
Cited
US5113855A
Cited
WO1991013646A1
Cited
US5351683A
Cited
WO1992008509A1
Cited
WO1993018811A1
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1998-11-27 | 1999-05-29 | 1999-11-28 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2002-11-27 | 2003-05-29 | 2003-11-28 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2006-11-27 | 2007-05-29 | 2007-11-28 | $7700.00 | Window Closed / Lapsed |